The Raise
Medow Health AI closed $3.5 million from existing investors, including Lifehouse CEO Professor Michael Boyer and orthopaedic surgeon Dr Michael Solomon. The company is calling this part of an $8.5 million seed round that includes a $3 million raise in November 2024 and $2 million in January 2025.
Three raises in nine months, all called "seed," raises questions about staging and dilution. No lead investor named, no new institutional money disclosed.
What They Sell
Medow started as an AI medical scribe for specialist doctors. Now they have added AI Front Desk: software that answers clinic calls, books appointments through existing practice management systems, and routes messages to staff. Calls get bumped to human receptionists when needed.
Target customer: specialist medical clinics (not GPs). The pitch is that up to half of patient calls go unanswered because reception staff are dealing with in-clinic patients. AI picks up the slack.
The company claims 1,000 specialist clinics across Australia and New Zealand are using the platform and projects three million consultations processed in 2026.
Sales Implications
This is healthcare vertical SaaS with a clear wedge: AI scribe to build trust, then upsell AI receptionist. Multi-product platform means potential for account expansion, higher ACV, and stickier customer relationships.
For anyone selling into this space, note the competitive dynamic: AI receptionist tools are attracting capital. Vocca raised $5.5 million recently for similar medical front-desk automation. Beside AI is active in the broader AI receptionist market. Smith.ai offers virtual receptionist services with human backup. The category is early but getting crowded.
What We Don't Know
No revenue figures. No disclosed ARR or customer count beyond "1,000 clinics." PitchBook data suggests Doctor AI (possibly the same entity or parent company) has been around since 2017 and raised $52 million total, including a $32.9 million Series D2 in 2021. If accurate, that means Medow is not a 2023 startup but a rebranded or repositioned business with years of runway and a mature commercial footprint.
No CRO, VP Sales, or go-to-market leadership named in available materials. For sales professionals eyeing this space, verify the actual org structure and comp before engaging.
Market Context
Healthcare AI front desk is a real category now. The wedge is simple: specialist clinics have thin reception teams, high call volume, and no tolerance for missed patient calls. AI voice agents are cheaper than hiring and can handle repetitive workflows (appointments, prescription refills, results calls) without burning out.
The challenge: clinical workflow integration, accuracy under regulatory scrutiny, and convincing doctors to trust AI with patient-facing comms. Medow's founder story (Joel Freiberg has Crohn's, his brother Josh co-founded, their dad is a respiratory physician) helps with credibility but does not replace clinical validation or references.
If you are selling AI sales tools, prospecting tools, or lead gen software, healthcare vertical plays like this are worth tracking. They show where AI adoption is moving fastest and where budget is shifting from headcount to software.